Low Density Lipoprotein Increased

4 drugs669 FAERS reportsMedDRA PT

GET

/api/v1/reaction/low-density-lipoprotein-increased

Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

Drugs reporting Low Density Lipoprotein Increased (4)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

1Inclisiran4796.4%
2Lomitapide1604.3%
3Sebelipase Alfa233.6%
4Evinacumab73.1%

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

What this is

Low Density Lipoprotein Increased is a MedDRA Preferred Term reported on FAERS adverse-event submissions. Each entry below is one drug from the dataset whose FAERS reports mention this reaction.

Try the API

cURLbash

curl https://pharmacopeia.dev/api/v1/reaction/low-density-lipoprotein-increased

Source

Source: openFDA · FAERS
Coding: MedDRA Preferred Term
Aliases: —

open.fda.gov/data/faers/

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Low Density Lipoprotein Increased

Drugs reporting Low Density Lipoprotein Increased (4)

Related reactions

Search pharmacopeia